問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberONO-4538-70/CA2099DX
Active

2018-06-01 - 2026-08-31

Phase III

Recruiting1

Terminated10

ICD-10C22

Malignant neoplasm of liver and intrahepatic bile ducts

ICD-10C22.0

Liver cell carcinoma

  • Trial Applicant

    PPD DEVELOPMENT (HK) LIMITED

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/04/01

Investigators and Locations

Principal Investigator Long-Bin Jeng Division of Others -

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator Yan-Shen Shan Division of General Surgery

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Audit

None

Principal Investigator Yi-Hsiang Huang Digestive System Department

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

13 Completed

Audit

None

Principal Investigator TENG-YU LEE Digestive System Department

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 洪肇宏 Digestive System Department

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 林正耀 Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator Chien-Hung Chen Division of General Internal Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator Jing-Houng Wang Digestive System Department

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator Ming-Chih Ho Division of General Surgery

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Audit

None

Principal Investigator Long-Bin Jeng 未分科

Co-Principal Investigator

Audit

None

Principal Investigator Shi-Ming Lin Digestive System Department

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

15 Completed

Audit

None

Principal Investigator 方佑仁 Division of General Internal Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    84 participants

  • Global

    883 participants